Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mundipharma International Corp. Ltd.

www.mundipharma.co.uk

Latest From URL Pharma Inc.

Congestion Continues In Private Label Mucinex Pipeline; Court Rules Against Mutual

A ruling for RB n Pennsylvania federal court comes as it girds for increased competition from additional guaifenesin expectorant formulations that are the equivalents of Mucinex brand products and that Perrigo is marketing under license from manufacturer Allergan.

Consumer BioPharmaceutical

Investors Boost Metabolic Companies

Investments in endocrine/metabolic disease-focused medtech companies reached a four-year high in 2015. Biopharma companies grabbed the majority of the funds that have been raised since 2012, and among medtechs, those focused on diabetes fared best.

BioPharmaceutical Medical Device

Mutual Alleges Mucinex Monopoly In Extended-Release Guaifenesin

Mutual Pharmaceutical alleges in an antitrust suit that RB attempts to monopolize the extended-release guaifenesin OTC category with its Mucinex product. The suit says Mutual has lost “tens of millions” due to RB's failure to honor a contract to supply an “authorized generic” of the product.

Consumer United States

Takeda Authorizes Colcrys Generic As Litigation Drags On

Takeda will manufacture the authorized generic version of its gout treatment to the same standards as the original and supply it to Prasco Laboratories for distribution in the U.S.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Mundipharma International Holdings Ltd.
  • Mundipharma International Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Mundipharma International Corp. Ltd.
  • Senior Management
  • Paul Medeiros, SVP, Corp. & Bus. Dev.
    Antony Mattessich, Managing Dir.
  • Contact Info
  • Mundipharma International Corp. Ltd.
    Phone: (44) 1223 424211
    Cambridge Science Park
    Unit 194
    Milton Rd., CB4 0AB
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register